https://discovertoimprove.com/2026/08/13/astrazeneca-sold-this-drug-for-5-million-its-now-worth-up-to-475-million/ 2026-08-13T00:32:34Z Cosmael Thinklab en AstraZeneca Sold This Drug for $5 Million. It's Now Worth Up to $475 Million 2026-08-13T00:32:32Z Blog https://discovertoimprove.com/2026/08/13/a-gene-that-should-stay-silent-is-poisoning-muscle-a-new-drug-just-told-it-to-shut-up/ 2026-08-13T00:28:09Z Cosmael Thinklab en A Gene That Should Stay Silent Is Poisoning Muscle. A New Drug Just Told It to Shut Up 2026-08-13T00:28:07Z Blog https://discovertoimprove.com/2026/08/13/a-heart-drug-europe-has-used-for-20-years-just-failed-its-big-american-test/ 2026-08-13T00:24:33Z Cosmael Thinklab en A Heart Drug Europe Has Used for 20 Years Just Failed Its Big American Test 2026-08-13T00:24:32Z Blog https://discovertoimprove.com/2026/08/13/cost-of-delay-quantified-an-ai-trial-monitor-is-valued-at-21-million-per-cancer-programme/ 2026-08-13T00:20:35Z Cosmael Thinklab en Cost of delay, quantified: an AI trial monitor is valued at $21 million per cancer programme 2026-08-13T00:20:34Z Blog https://discovertoimprove.com/2026/08/12/rejected-on-the-factory-floor-the-fda-turned-down-a-cancer-drug-without-questioning-the-data/ 2026-08-12T02:33:58Z Cosmael Thinklab en Rejected on the factory floor: the FDA turned down a cancer drug without questioning the data 2026-08-12T02:33:56Z Blog https://discovertoimprove.com/2026/08/12/small-molecule-big-difference-the-glp-1-pill-problem-was-never-the-receptor/ 2026-08-12T02:17:55Z Cosmael Thinklab en Small molecule, big difference: the GLP-1 pill problem was never the receptor 2026-08-12T02:17:54Z Blog https://discovertoimprove.com/2026/08/12/partial-inhibition-by-design-the-rare-disease-drug-that-deliberately-stops-at-80/ 2026-08-12T01:38:02Z Cosmael Thinklab en Partial inhibition, by design: the rare-disease drug that deliberately stops at 80% 2026-08-12T01:38:01Z Blog